참고문헌
- Hirose S, Hamashima Y. Morphological observation on the vasculitis in the mucocutaneous lymph node syndrome: a skin biopsy study of 27 patients. Eur J Pediatr 1978;129: 17-27 https://doi.org/10.1007/BF00441370
- Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease : pathology and morphogenesis of the vascular changes. Jpn Circ J 1979:43:633-43 https://doi.org/10.1253/jcj.43.633
- Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999;83:337-9 https://doi.org/10.1016/S0002-9149(98)00864-9
- Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, et al. Systemic production of vascular endothelial growth factor and frns-Iike tyrosine kinase-I receptor in acute Kawasaki disease. Circulation 2002;105:766-9 https://doi.org/10.1161/hc0602.103396
- Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor gene is expressed differentially in normal tissues, macrophages, and tumors. Mol BioI Cell 1992;3:211-20 https://doi.org/10.1091/mbc.3.2.211
- Ferrara N, Henzel WJ. Pituitary follicular cells secret a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8 https://doi.org/10.1016/0006-291X(89)92678-8
- Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrare N. Vascular endothelial growth factor is a screted angiogenic mitogen. Science 1989;246:1306-9 https://doi.org/10.1126/science.2479986
- Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J. et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-12 https://doi.org/10.1126/science.2479987
- Tischer E, Gosporadowicz D, Mitchell R, Silva M, Schilling J, Lau K, et al. Vascular endothelial growth factor : a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989;165:1198-206 https://doi.org/10.1016/0006-291X(89)92729-0
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observations of 50 cases (in Japanese). Arerugi 1967;16:178-222
- Ohno T, Igarashi H, Inoue K, Akazawa K, Joh-o K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2000;159:424-9 https://doi.org/10.1007/s004310051300
- Seko Y, Imai Y, Suzuki S. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci 1997;92: 453-4 https://doi.org/10.1042/cs0920453
- Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajirna I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998:44:5969
- Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C. Remodeling of coronary artery lesions due to Kawasaki disease. Japan Heart J 2000:41:245-56 https://doi.org/10.1536/jhj.41.245
- Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease. Circulation 2000;101:2935-41 https://doi.org/10.1161/01.CIR.101.25.2935
- American Heart Association, Inc. Adapted in part from the Japan Kawasaki Disease Research Committee. Circulation 2001;103:335-6 https://doi.org/10.1161/01.CIR.103.2.335
- Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-13 https://doi.org/10.1016/S0022-3476(87)80503-6
- Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatrics international 2002;44:1-4 https://doi.org/10.1046/j.1442-200X.2002.01508.x
- Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126: 524-9
- Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DY, Wilson H, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986; 109:759-63 https://doi.org/10.1016/S0022-3476(86)80689-8
- Takeshita S, Kawamura Y, Takabayashi H, Yoshida N, Nonoyama S. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clinical and Experimental Immunology 2005;139:575-9 https://doi.org/10.1111/j.1365-2249.2005.02714.x
- Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993;123:657-9 https://doi.org/10.1016/S0022-3476(05)80972-2
- Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000;154:694-9 https://doi.org/10.1001/archpedi.154.7.694
- Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105(6):E78 https://doi.org/10.1542/peds.105.6.e78
- Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matumoto Y, et al. Prediction of non-response to intravenous high-dose gammaglobulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000;137:172-6 https://doi.org/10.1067/mpd.2000.104815
- Durongpisitkul K, Soongswang J. Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C, et al. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003;24:145-8 https://doi.org/10.1007/s00246-002-0216-2
- Zee R, Murohara T, Lou Z, Zollmann F, Passeri J, Lekutat C, et al. Vascular endothelial growth factor/Vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997;95: 1030-7 https://doi.org/10.1161/01.CIR.95.4.1030
- Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131-9 https://doi.org/10.1172/JCI119868
- Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997; 3:879-86 https://doi.org/10.1038/nm0897-879
- Burns JC, Glode MP, Clarke SH, Wiggins J Jr, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of artery aneurysms. J Pediatr 1984;105:206-11 https://doi.org/10.1016/S0022-3476(84)80114-6
- Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998;31:1074-80 https://doi.org/10.1016/S0735-1097(98)00033-3
- Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997; 96:454-61
- Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease : review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-92 https://doi.org/10.1016/S0022-3476(86)80878-2
- Ichida F, Fatica NS, Engle MA, O'Loughlin JE, Klein AA, Snyder MS, et al. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York : risk factors and role of aspirin. Pediatrics 1987;80:828-35
- Daniels SR, Specker B, Capannari TE, Schwartz DC, Burke MJ, Kaplan S. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child 1987;141:205-7
- Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 2003;143:363-7 https://doi.org/10.1067/S0022-3476(03)00387-1
- Harada K, Yamaguchi H, Kato H, Nishibayashi Y, Ichiro S, Okazaki T, et al. Indication for intravenous gamma globulin treatment for Kawasaki disease. American Heart Association 1993:459-62
- Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10 https://doi.org/10.1111/j.1442-200X.1991.tb02612.x
- Beiser AS, Takahasha M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. Am J Cardiol 1998;81:1116-20 https://doi.org/10.1016/S0002-9149(98)00116-7
- Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80 https://doi.org/10.1161/01.CIR.87.5.1776